| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 5.66e-07 | 37 | 166 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.68e-07 | 38 | 166 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.10e-05 | 227 | 166 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TMEM201 ANK3 MYO7B DBNL ARFGEF2 APOE DYSF CCDC88B KIF24 MAPK8IP3 TAOK2 MICALL2 STARD9 NISCH AVIL TLN1 TLN2 KIF2A TAGLN2 MYO18B CORO7 UNC13A VCL | 4.13e-05 | 1099 | 166 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | COMP ANK3 LAD1 DBNL NECTIN3 LILRB1 NLGN3 NISCH TLN1 TLN2 TNKS1BP1 TAGLN2 CTNND2 CX3CL1 VSIG10L2 VCL | 4.15e-05 | 599 | 166 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 8.86e-05 | 11 | 166 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.92e-04 | 14 | 166 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | IkappaB kinase activity | 2.05e-04 | 3 | 166 | 2 | GO:0008384 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 6.72e-04 | 21 | 166 | 3 | GO:0035613 | |
| GeneOntologyBiologicalProcess | positive regulation of type I interferon production | 3.46e-06 | 81 | 162 | 7 | GO:0032481 | |
| GeneOntologyBiologicalProcess | regulation of type I interferon production | 1.59e-05 | 141 | 162 | 8 | GO:0032479 | |
| GeneOntologyBiologicalProcess | type I interferon production | 1.95e-05 | 145 | 162 | 8 | GO:0032606 | |
| GeneOntologyBiologicalProcess | regulation of glutamate receptor signaling pathway | 2.59e-05 | 8 | 162 | 3 | GO:1900449 | |
| GeneOntologyBiologicalProcess | macrophage cytokine production | 7.12e-05 | 55 | 162 | 5 | GO:0010934 | |
| GeneOntologyBiologicalProcess | endolysosomal toll-like receptor signaling pathway | 7.77e-05 | 56 | 162 | 5 | GO:0140894 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 VPS4A WWP1 OAS1 RCC1 ERVK-7 NECTIN3 APOE TYRO3 GRK2 CLEC4G ERVK-8 ERVK-19 | 7.93e-05 | 464 | 162 | 13 | GO:0016032 |
| GeneOntologyBiologicalProcess | defense response to virus | MYD88 TICAM1 OAS1 IRF1 AZI2 LILRB1 CHUK IKBKE PRF1 TLR3 MICA | 8.55e-05 | 342 | 162 | 11 | GO:0051607 |
| GeneOntologyBiologicalProcess | toll-like receptor 3 signaling pathway | 9.78e-05 | 31 | 162 | 4 | GO:0034138 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor production | 1.10e-04 | 237 | 162 | 9 | GO:0032640 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | COMP ANK3 NT5E IRF1 PODXL2 NECTIN3 CCDC88B LILRB1 TAOK2 TYRO3 NLGN3 FAT2 TLN1 CLEC4G ASTN1 TLN2 CTNND2 CX3CL1 MUC4 VSIG10L2 VCL | 1.11e-04 | 1077 | 162 | 21 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of macrophage cytokine production | 1.26e-04 | 33 | 162 | 4 | GO:0060907 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 1.26e-04 | 33 | 162 | 4 | GO:0000289 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.28e-04 | 13 | 162 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor superfamily cytokine production | 1.33e-04 | 243 | 162 | 9 | GO:0071706 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.62e-04 | 14 | 162 | 3 | GO:0060213 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.64e-04 | 147 | 162 | 7 | GO:0099565 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | MYD88 TICAM1 OAS1 IRF1 APOE LILRB1 CHUK TYRO3 IKBKE NFKBIA TLR3 MICA INAVA CX3CL1 MUC4 | 1.72e-04 | 643 | 162 | 15 | GO:0002831 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.75e-04 | 198 | 162 | 8 | GO:0048813 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 2.25e-04 | 70 | 162 | 5 | GO:0001913 | |
| GeneOntologyBiologicalProcess | cell junction organization | PSEN2 ANK3 DBNL NECTIN3 APOE CHRNB2 TAOK2 KY NLGN3 MICALL2 TLN1 ANAPC2 TLN2 INAVA CTNND2 CX3CL1 UNC13A VCL EPHA4 | 2.39e-04 | 974 | 162 | 19 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of innate immune response | MYD88 TICAM1 OAS1 IRF1 APOE LILRB1 CHUK TYRO3 IKBKE NFKBIA TLR3 MICA INAVA | 2.39e-04 | 519 | 162 | 13 | GO:0045088 |
| GeneOntologyBiologicalProcess | toll-like receptor 4 signaling pathway | 2.41e-04 | 71 | 162 | 5 | GO:0034142 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.47e-04 | 16 | 162 | 3 | GO:0060211 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte cytokine production | 2.57e-04 | 72 | 162 | 5 | GO:0061082 | |
| GeneOntologyBiologicalProcess | interferon-beta production | 2.74e-04 | 73 | 162 | 5 | GO:0032608 | |
| GeneOntologyBiologicalProcess | regulation of interferon-beta production | 2.74e-04 | 73 | 162 | 5 | GO:0032648 | |
| GeneOntologyBiologicalProcess | canonical NF-kappaB signal transduction | 2.90e-04 | 330 | 162 | 10 | GO:0007249 | |
| GeneOntologyBiologicalProcess | synapse organization | PSEN2 ANK3 DBNL NECTIN3 APOE CHRNB2 TAOK2 KY NLGN3 ANAPC2 TLN2 CTNND2 CX3CL1 UNC13A EPHA4 | 3.38e-04 | 685 | 162 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | interleukin-6 production | 3.68e-04 | 221 | 162 | 8 | GO:0032635 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | TRPV1 PSEN2 APOE DYSF LILRB1 SHC3 CHRNB2 TMEM25 NLGN3 GRK2 NPFF NISCH ANAPC2 CTNND2 CADPS2 CX3CL1 UNC13A EPHA4 | 3.90e-04 | 931 | 162 | 18 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | TRPV1 PSEN2 APOE DYSF LILRB1 SHC3 CHRNB2 TMEM25 NLGN3 GRK2 NPFF NISCH ANAPC2 CTNND2 CADPS2 CX3CL1 UNC13A EPHA4 | 3.90e-04 | 931 | 162 | 18 | GO:0007268 |
| GeneOntologyBiologicalProcess | cell surface toll-like receptor signaling pathway | 3.96e-04 | 79 | 162 | 5 | GO:0140895 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | TRPV1 PSEN2 APOE DYSF LILRB1 SHC3 CHRNB2 TMEM25 NLGN3 GRK2 NPFF NISCH ANAPC2 CTNND2 CADPS2 CX3CL1 UNC13A EPHA4 | 4.32e-04 | 939 | 162 | 18 | GO:0099537 |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte cytokine production involved in immune response | 4.63e-04 | 46 | 162 | 4 | GO:0061081 | |
| GeneOntologyBiologicalProcess | positive regulation of interferon-beta production | 5.03e-04 | 47 | 162 | 4 | GO:0032728 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 5.29e-04 | 293 | 162 | 9 | GO:0048167 | |
| GeneOntologyBiologicalProcess | pattern recognition receptor signaling pathway | 5.43e-04 | 294 | 162 | 9 | GO:0002221 | |
| GeneOntologyBiologicalProcess | regulation of macrophage cytokine production | 5.45e-04 | 48 | 162 | 4 | GO:0010935 | |
| GeneOntologyBiologicalProcess | response to interferon-beta | 5.45e-04 | 48 | 162 | 4 | GO:0035456 | |
| GeneOntologyBiologicalProcess | response to virus | MYD88 TICAM1 OAS1 IRF1 AZI2 LILRB1 CHUK IKBKE PRF1 TLR3 MICA | 5.52e-04 | 425 | 162 | 11 | GO:0009615 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 5.62e-04 | 180 | 162 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 5.72e-04 | 130 | 162 | 6 | GO:0060079 | |
| GeneOntologyBiologicalProcess | regulation of canonical NF-kappaB signal transduction | 5.98e-04 | 298 | 162 | 9 | GO:0043122 | |
| GeneOntologyBiologicalProcess | positive regulation of glutamate receptor signaling pathway | 6.04e-04 | 5 | 162 | 2 | GO:1900451 | |
| GeneOntologyBiologicalProcess | cell surface pattern recognition receptor signaling pathway | 6.18e-04 | 87 | 162 | 5 | GO:0002752 | |
| GeneOntologyBiologicalProcess | toll-like receptor signaling pathway | 6.51e-04 | 88 | 162 | 5 | GO:0002224 | |
| GeneOntologyBiologicalProcess | I-kappaB phosphorylation | 6.56e-04 | 22 | 162 | 3 | GO:0007252 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 6.61e-04 | 185 | 162 | 7 | GO:0099175 | |
| GeneOntologyBiologicalProcess | synaptic signaling | TRPV1 PSEN2 APOE DYSF LILRB1 SHC3 CHRNB2 TMEM25 NLGN3 GRK2 NPFF NISCH ANAPC2 CTNND2 CADPS2 CX3CL1 UNC13A EPHA4 | 6.78e-04 | 976 | 162 | 18 | GO:0099536 |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 7.26e-04 | 188 | 162 | 7 | GO:0002753 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | MYD88 TICAM1 ARFGEF2 OAS1 IRF1 CCDC88B LILRB1 CHUK GRK2 IKBKE TLR3 INAVA CX3CL1 | 7.51e-04 | 586 | 162 | 13 | GO:0001819 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | PSEN2 APOE DYSF LILRB1 CHRNB2 TMEM25 NLGN3 GRK2 NISCH ANAPC2 CTNND2 CX3CL1 UNC13A EPHA4 | 7.63e-04 | 663 | 162 | 14 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | PSEN2 APOE DYSF LILRB1 CHRNB2 TMEM25 NLGN3 GRK2 NISCH ANAPC2 CTNND2 CX3CL1 UNC13A EPHA4 | 7.74e-04 | 664 | 162 | 14 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 7.96e-04 | 53 | 162 | 4 | GO:0001914 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 8.28e-04 | 312 | 162 | 9 | GO:0002758 | |
| MousePheno | abnormal response to injury | MYD88 NPR1 TRPV1 COMP NT5E TICAM1 IRF1 SIRT7 APOE DYSF CHRNB2 AEBP1 TLR3 BUB1B CORO7 CX3CL1 BBC3 SERPIND1 | 7.31e-06 | 607 | 125 | 18 | MP:0005164 |
| MousePheno | abnormal maternal nurturing | 4.25e-05 | 105 | 125 | 7 | MP:0001386 | |
| MousePheno | increased susceptibility to Picornaviridae infection | 4.73e-05 | 23 | 125 | 4 | MP:0020937 | |
| MousePheno | increased susceptibility to Coronaviridae infection | 5.64e-05 | 24 | 125 | 4 | MP:0020949 | |
| MousePheno | increased susceptibility to Riboviria infection | 6.81e-05 | 113 | 125 | 7 | MP:0020913 | |
| MousePheno | abnormal maternal behavior | 7.61e-05 | 115 | 125 | 7 | MP:0008779 | |
| MousePheno | decreased tumor necrosis factor secretion | 1.29e-04 | 125 | 125 | 7 | MP:0008561 | |
| MousePheno | increased susceptibility to Riboviria infection induced morbidity/mortality | 1.40e-04 | 56 | 125 | 5 | MP:0031024 | |
| MousePheno | increased susceptibility to viral infection | 1.55e-04 | 172 | 125 | 8 | MP:0002418 | |
| MousePheno | abnormal retina progenitor cell morphology | 1.87e-04 | 13 | 125 | 3 | MP:0006071 | |
| MousePheno | abnormal response to infection | MYD88 TICAM1 OAS1 IRF1 APOE TGM6 KDM6B CCDC88B SIGLEC7 IKBKE PRF1 NFKBIA TLR3 CLEC4G INAVA ZKSCAN4 MUC4 | 2.05e-04 | 714 | 125 | 17 | MP:0005025 |
| MousePheno | increased susceptibility to Herpesvirales infection | 2.10e-04 | 61 | 125 | 5 | MP:0020916 | |
| MousePheno | abnormal tumor necrosis factor secretion | 2.21e-04 | 230 | 125 | 9 | MP:0008556 | |
| MousePheno | abnormal NK T cell physiology | 2.36e-04 | 14 | 125 | 3 | MP:0008042 | |
| MousePheno | increased left ventricle developed pressure | 2.37e-04 | 3 | 125 | 2 | MP:0003823 | |
| MousePheno | abnormal response to antigen | MYD88 TICAM1 OAS1 IRF1 APOE TGM6 KDM6B CCDC88B SIGLEC7 IKBKE PRF1 NFKBIA TLR3 CLEC4G INAVA ZKSCAN4 MUC4 | 2.49e-04 | 726 | 125 | 17 | MP:0020000 |
| Domain | Ago_hook | 6.17e-07 | 3 | 160 | 3 | PF10427 | |
| Domain | TNRC6_PABC-bd | 6.17e-07 | 3 | 160 | 3 | IPR032226 | |
| Domain | Argonaute_hook_dom | 6.17e-07 | 3 | 160 | 3 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 6.17e-07 | 3 | 160 | 3 | PF16608 | |
| Domain | Vinculin/catenin | 2.11e-05 | 7 | 160 | 3 | IPR006077 | |
| Domain | - | 7.29e-05 | 2 | 160 | 2 | 1.20.1420.10 | |
| Domain | VBS | 7.29e-05 | 2 | 160 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 7.29e-05 | 2 | 160 | 2 | IPR015009 | |
| Domain | Talin_cent | 7.29e-05 | 2 | 160 | 2 | IPR015224 | |
| Domain | M_domain | 7.29e-05 | 2 | 160 | 2 | PF12938 | |
| Domain | GW182_M_dom | 7.29e-05 | 2 | 160 | 2 | IPR026805 | |
| Domain | Talin_middle | 7.29e-05 | 2 | 160 | 2 | PF09141 | |
| Domain | C2 | 1.36e-04 | 131 | 160 | 7 | PF00168 | |
| Domain | C2 | 1.80e-04 | 137 | 160 | 7 | SM00239 | |
| Domain | Talin-1 | 2.18e-04 | 3 | 160 | 2 | IPR015710 | |
| Domain | C2 | 2.24e-04 | 142 | 160 | 7 | PS50004 | |
| Domain | ILWEQ_dom | 4.33e-04 | 4 | 160 | 2 | IPR002558 | |
| Domain | ILWEQ | 4.33e-04 | 4 | 160 | 2 | SM00307 | |
| Domain | FERM_f0 | 4.33e-04 | 4 | 160 | 2 | PF16511 | |
| Domain | ILWEQ | 4.33e-04 | 4 | 160 | 2 | PD011820 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 4.33e-04 | 4 | 160 | 2 | PF01608 | |
| Domain | I_LWEQ | 4.33e-04 | 4 | 160 | 2 | PS50945 | |
| Domain | FERM_f0 | 4.33e-04 | 4 | 160 | 2 | IPR032425 | |
| Domain | C2_dom | 5.37e-04 | 164 | 160 | 7 | IPR000008 | |
| Domain | DUF1041 | 7.17e-04 | 5 | 160 | 2 | SM01145 | |
| Domain | ZF_HIT | 1.07e-03 | 6 | 160 | 2 | PS51083 | |
| Domain | zf-HIT | 1.07e-03 | 6 | 160 | 2 | PF04438 | |
| Domain | Znf_HIT | 1.07e-03 | 6 | 160 | 2 | IPR007529 | |
| Domain | TIR | 1.09e-03 | 24 | 160 | 3 | PS50104 | |
| Domain | TIR_dom | 1.24e-03 | 25 | 160 | 3 | IPR000157 | |
| Domain | Munc13_1 | 1.49e-03 | 7 | 160 | 2 | IPR014770 | |
| Domain | MHD1 | 1.49e-03 | 7 | 160 | 2 | PS51258 | |
| Domain | DUF1041 | 1.49e-03 | 7 | 160 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.49e-03 | 7 | 160 | 2 | IPR010439 | |
| Pathway | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1 | 1.38e-07 | 17 | 108 | 5 | M583 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION | 1.65e-07 | 33 | 108 | 6 | M39909 | |
| Pathway | REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS | 4.44e-07 | 21 | 108 | 5 | M26978 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY | 6.60e-07 | 10 | 108 | 4 | M47601 | |
| Pathway | WP_TLR4_SIGNALING_AND_TOLERANCE | 2.05e-06 | 28 | 108 | 5 | M39561 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88 | 3.49e-06 | 31 | 108 | 5 | M39573 | |
| Pathway | REACTOME_DISEASES_OF_IMMUNE_SYSTEM | 4.11e-06 | 32 | 108 | 5 | M27428 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 4.81e-06 | 33 | 108 | 5 | MM15940 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.50e-05 | 7 | 108 | 3 | M46421 | |
| Pathway | PID_TOLL_ENDOGENOUS_PATHWAY | 3.08e-05 | 24 | 108 | 4 | M264 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 3.55e-05 | 9 | 108 | 3 | M27810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 3.55e-05 | 9 | 108 | 3 | M47451 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 3.55e-05 | 9 | 108 | 3 | M47725 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 3.55e-05 | 9 | 108 | 3 | M46436 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 3.64e-05 | 25 | 108 | 4 | M984 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 5.05e-05 | 10 | 108 | 3 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION | 6.90e-05 | 11 | 108 | 3 | M48241 | |
| Pathway | WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION | 8.74e-05 | 31 | 108 | 4 | M39859 | |
| Pathway | REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS | 1.18e-04 | 13 | 108 | 3 | MM14616 | |
| Pathway | REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7 | 1.18e-04 | 13 | 108 | 3 | M27884 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 1.18e-04 | 13 | 108 | 3 | M46434 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 1.28e-04 | 64 | 108 | 5 | M27046 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.30e-04 | 102 | 108 | 6 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 1.38e-04 | 103 | 108 | 6 | M39434 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.77e-04 | 37 | 108 | 4 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 2.65e-04 | 41 | 108 | 4 | M29748 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 2.75e-04 | 17 | 108 | 3 | M27788 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY | 2.75e-04 | 17 | 108 | 3 | M47912 | |
| Pathway | WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING | 3.19e-04 | 43 | 108 | 4 | M39744 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 3.29e-04 | 170 | 108 | 7 | M7494 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 3.88e-04 | 19 | 108 | 3 | M48238 | |
| Pathway | REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT | 3.88e-04 | 19 | 108 | 3 | M27020 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 3.88e-04 | 19 | 108 | 3 | M47450 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 4.51e-04 | 47 | 108 | 4 | M29777 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY | 4.53e-04 | 20 | 108 | 3 | M47563 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 4.53e-04 | 20 | 108 | 3 | MM1476 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 4.86e-04 | 130 | 108 | 6 | MM15455 | |
| Pathway | WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY | 4.89e-04 | 48 | 108 | 4 | MM15897 | |
| Pathway | BIOCARTA_NFKB_PATHWAY | 5.26e-04 | 21 | 108 | 3 | MM1444 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 5.26e-04 | 21 | 108 | 3 | M1001 | |
| Pathway | BIOCARTA_NFKB_PATHWAY | 5.26e-04 | 21 | 108 | 3 | M15285 | |
| Pathway | WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19 | 5.26e-04 | 21 | 108 | 3 | M40061 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 5.27e-04 | 132 | 108 | 6 | M724 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 5.29e-04 | 49 | 108 | 4 | M48250 | |
| Pathway | WP_APOPTOSIS | 5.69e-04 | 88 | 108 | 5 | M39654 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 6.06e-04 | 22 | 108 | 3 | MM1443 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 6.17e-04 | 136 | 108 | 6 | M42547 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 6.93e-04 | 23 | 108 | 3 | M2821 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 7.87e-04 | 24 | 108 | 3 | MM1518 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 8.55e-04 | 6 | 108 | 2 | MM15083 | |
| Pathway | REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH | 8.55e-04 | 6 | 108 | 2 | M27883 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY | 8.55e-04 | 6 | 108 | 2 | M47462 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.01e-03 | 58 | 108 | 4 | M11980 | |
| Pathway | WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY | 1.14e-03 | 60 | 108 | 4 | M39583 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 1.18e-03 | 154 | 108 | 6 | M27697 | |
| Pathway | REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID | 1.19e-03 | 7 | 108 | 2 | M27463 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY | 1.19e-03 | 7 | 108 | 2 | M47464 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.25e-03 | 28 | 108 | 3 | M48253 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.29e-03 | 62 | 108 | 4 | M27321 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.53e-03 | 30 | 108 | 3 | M47724 | |
| Pathway | WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS | 1.54e-03 | 65 | 108 | 4 | M39354 | |
| Pathway | WP_CANONICAL_NFKB_PATHWAY | 1.58e-03 | 8 | 108 | 2 | M39783 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY | 1.58e-03 | 8 | 108 | 2 | M47463 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 1.68e-03 | 31 | 108 | 3 | M12095 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.68e-03 | 31 | 108 | 3 | M39897 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.85e-03 | 32 | 108 | 3 | M48012 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 1.85e-03 | 32 | 108 | 3 | MM14707 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.85e-03 | 32 | 108 | 3 | M27900 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R | 2.02e-03 | 33 | 108 | 3 | M39803 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 2.02e-03 | 33 | 108 | 3 | MM14666 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 2.02e-03 | 33 | 108 | 3 | MM1426 | |
| Pathway | WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2 | 2.02e-03 | 33 | 108 | 3 | M40066 | |
| Pathway | WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT | 2.02e-03 | 9 | 108 | 2 | M39757 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY | 2.02e-03 | 9 | 108 | 2 | M47598 | |
| Pathway | WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD | 2.02e-03 | 9 | 108 | 2 | M39509 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY | 2.02e-03 | 9 | 108 | 2 | M47652 | |
| Pathway | BIOCARTA_RNA_PATHWAY | 2.02e-03 | 9 | 108 | 2 | MM1382 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY | 2.02e-03 | 9 | 108 | 2 | M47734 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.13e-03 | 71 | 108 | 4 | M15913 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 2.20e-03 | 34 | 108 | 3 | M3342 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 2.20e-03 | 34 | 108 | 3 | M46422 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 2.39e-03 | 35 | 108 | 3 | M27190 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY | 2.51e-03 | 10 | 108 | 2 | M47599 | |
| Pathway | BIOCARTA_RNA_PATHWAY | 2.51e-03 | 10 | 108 | 2 | M10570 | |
| Pathway | REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX | 3.06e-03 | 11 | 108 | 2 | M27885 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY | 3.06e-03 | 11 | 108 | 2 | M47493 | |
| Pubmed | Kinetic of RelA activation controls magnitude of TLR-mediated IL-12p40 induction. | 6.65e-08 | 9 | 169 | 4 | 19201871 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 19952892 | ||
| Pubmed | Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. | 1.13e-07 | 3 | 169 | 3 | 15494027 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 16880270 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 31670606 | ||
| Pubmed | Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. | 1.13e-07 | 3 | 169 | 3 | 27816808 | |
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 1.13e-07 | 3 | 169 | 3 | 34108231 | |
| Pubmed | Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility. | 1.13e-07 | 3 | 169 | 3 | 30853218 | |
| Pubmed | Vinculin controls talin engagement with the actomyosin machinery. | 1.13e-07 | 3 | 169 | 3 | 26634421 | |
| Pubmed | A role for granzyme M in TLR4-driven inflammation and endotoxicosis. | 3.72e-07 | 13 | 169 | 4 | 20585036 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 14625548 | ||
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 4.49e-07 | 4 | 169 | 3 | 21063388 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 29041928 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 25152077 | ||
| Pubmed | TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. | 4.49e-07 | 4 | 169 | 3 | 20957750 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 19158348 | ||
| Pubmed | Extracellular MicroRNAs Induce Potent Innate Immune Responses via TLR7/MyD88-Dependent Mechanisms. | 4.49e-07 | 4 | 169 | 3 | 28768728 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 22318993 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 17573354 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 26363072 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 17982077 | ||
| Pubmed | Vinculin regulates assembly of talin: β3 integrin complexes. | 4.49e-07 | 4 | 169 | 3 | 24446374 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX3 WWP1 RTTN LAD1 ARFGEF2 TNRC6C KDM6B DYSF MAPK8IP3 TAOK2 CCDC142 ARHGEF40 NISCH TLN1 HELZ2 NINL TLN2 TNKS1BP1 CEP131 HR | 4.86e-07 | 1105 | 169 | 20 | 35748872 |
| Pubmed | 5.19e-07 | 14 | 169 | 4 | 30510167 | ||
| Pubmed | RBBP8 TTC27 TNRC6B RCC1 BCOR RBM20 BUB1B TNRC6A TNKS1BP1 CEP131 ZKSCAN4 WDR62 | 1.08e-06 | 418 | 169 | 12 | 34709266 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 18057004 | ||
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 16365431 | ||
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 25756897 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.12e-06 | 5 | 169 | 3 | 12629516 | |
| Pubmed | Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. | 1.12e-06 | 5 | 169 | 3 | 24698267 | |
| Pubmed | ZNF133 SESTD1 ANK3 USP11 ARFGEF2 TTC27 ZNF202 APOE KDM6B MAPK8IP3 CHUK CYRIA KANSL2 NISCH NABP2 ASTN1 TLN2 USP54 CTNND2 CADPS2 TARBP1 | 1.27e-06 | 1285 | 169 | 21 | 35914814 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 17190817 | ||
| Pubmed | The TLR4-TRIF pathway protects against H5N1 influenza virus infection. | 2.23e-06 | 6 | 169 | 3 | 22031950 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 22124111 | ||
| Pubmed | Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. | 2.23e-06 | 6 | 169 | 3 | 22925892 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 9914500 | ||
| Pubmed | New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. | 2.23e-06 | 6 | 169 | 3 | 30046112 | |
| Pubmed | Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. | 2.23e-06 | 6 | 169 | 3 | 24572365 | |
| Pubmed | Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. | 2.23e-06 | 6 | 169 | 3 | 16625202 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 16301743 | ||
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 17142768 | ||
| Pubmed | UNC93B1 mediates host resistance to infection with Toxoplasma gondii. | 2.23e-06 | 6 | 169 | 3 | 20865117 | |
| Pubmed | The role of hyaluronan degradation products as innate alloimmune agonists. | 2.23e-06 | 6 | 169 | 3 | 17049055 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 11959143 | ||
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 28564605 | ||
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 28970238 | ||
| Pubmed | Interferon inducible GBPs restrict Burkholderia thailandensis motility induced cell-cell fusion. | 2.45e-06 | 20 | 169 | 4 | 32150572 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 19995952 | ||
| Pubmed | IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. | 3.89e-06 | 7 | 169 | 3 | 12692549 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 25964372 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 19383768 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 23266827 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 25937283 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 23408632 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 22072781 | ||
| Pubmed | Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. | 3.89e-06 | 7 | 169 | 3 | 19009526 | |
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 3.89e-06 | 7 | 169 | 3 | 19470757 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 16142239 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 37851573 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 19406986 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 22184724 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 22123964 | ||
| Pubmed | A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. | 3.89e-06 | 7 | 169 | 3 | 16286919 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 16272328 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 27716849 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | TNRC6B AZI2 TNRC6C CHUK GRK2 BUB1B TNRC6A TAGLN2 USP54 CORO7 | 4.39e-06 | 322 | 169 | 10 | 39098523 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TOR1AIP2 PPP1R12B NOL6 TTC27 TNRC6B URB2 TNRC6C RAB18 IQCC PROSER3 NINL UQCC1 CEP131 USP54 MOCOS | 4.63e-06 | 754 | 169 | 15 | 33060197 |
| Pubmed | SESTD1 ANK3 HECW1 PDE1B WDR7 TNRC6B BCOR MAPK8IP3 TAOK2 NLGN3 NISCH TLN2 CEP131 KIF2A CTNND2 UNC13A EPHA4 | 5.14e-06 | 963 | 169 | 17 | 28671696 | |
| Pubmed | 5.30e-06 | 24 | 169 | 4 | 34526512 | ||
| Pubmed | Dengue hemorrhagic fever is associated with polymorphisms in JAK1. | 5.70e-06 | 91 | 169 | 6 | 20588308 | |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 18981140 | ||
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 18322244 | ||
| Pubmed | The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. | 6.20e-06 | 8 | 169 | 3 | 21998457 | |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 27459510 | ||
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 23349877 | ||
| Pubmed | Uncoupling between inflammatory and fibrotic responses to silica: evidence from MyD88 knockout mice. | 6.20e-06 | 8 | 169 | 3 | 25050810 | |
| Pubmed | Cytokine regulation of lung Th17 response to airway immunization using LPS adjuvant. | 6.20e-06 | 8 | 169 | 3 | 27328989 | |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 17568778 | ||
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 22017400 | ||
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 19017982 | ||
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 19120481 | ||
| Pubmed | Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. | 9.27e-06 | 9 | 169 | 3 | 12872135 | |
| Pubmed | 9.27e-06 | 9 | 169 | 3 | 16210631 | ||
| Pubmed | Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes. | 9.27e-06 | 9 | 169 | 3 | 20449947 | |
| Pubmed | Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. | 9.27e-06 | 9 | 169 | 3 | 30923196 | |
| Pubmed | Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. | 9.27e-06 | 9 | 169 | 3 | 12855817 | |
| Pubmed | TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. | 9.27e-06 | 9 | 169 | 3 | 18256672 | |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 31852751 | ||
| Pubmed | Assembly of the cochlear gap junction macromolecular complex requires connexin 26. | 1.32e-05 | 10 | 169 | 3 | 24590285 | |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 17992263 | ||
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 28894449 | ||
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 20124105 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NPR1 PPP1R12B TTC27 KIF24 KANSL2 ZNHIT6 MICALL2 TLN1 ANAPC2 BUB1B TLN2 TNKS1BP1 CEP131 TAGLN2 ATL2 ZNHIT2 VCL WDR62 | 1.45e-05 | 1155 | 169 | 18 | 20360068 |
| Pubmed | 1.55e-05 | 225 | 169 | 8 | 12168954 | ||
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 24391503 | ||
| Pubmed | Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. | 1.81e-05 | 11 | 169 | 3 | 20975040 | |
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 23962979 | ||
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 20037584 | ||
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 22896628 | ||
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 23843525 | ||
| Interaction | IQCC interactions | 5.96e-08 | 14 | 162 | 5 | int:IQCC | |
| Interaction | TBKBP1 interactions | 3.70e-06 | 80 | 162 | 7 | int:TBKBP1 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 9.03e-06 | 25 | 97 | 4 | 775 | |
| GeneFamily | Zinc fingers HIT-type | 4.21e-04 | 6 | 97 | 2 | 83 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.40e-04 | 36 | 97 | 3 | 823 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.92e-03 | 46 | 97 | 3 | 622 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.44e-03 | 50 | 97 | 3 | 1293 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 2.86e-03 | 15 | 97 | 2 | 1296 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.53e-08 | 171 | 164 | 9 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-06 | 170 | 164 | 7 | 81341bf4fe090af70b2091b6b2579ed08d76e22d | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.36e-06 | 188 | 164 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.59e-06 | 189 | 164 | 7 | 0fe8901e10c619c93b7788792da1706a32102c6e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.06e-06 | 191 | 164 | 7 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.06e-06 | 191 | 164 | 7 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-06 | 192 | 164 | 7 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 126 | 164 | 6 | 83f3540683b3b175b10af059ab8898c46eaccc13 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 126 | 164 | 6 | 6d5075d659dac7b96e6857f8485a7d2c4105d685 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 126 | 164 | 6 | fd0001a0f3a0a4421f96fd21813c21cf6f01d40e | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 126 | 164 | 6 | f20424f9baf3c4059cd6b701761e7595400fc47c | |
| ToppCell | Mild/Remission-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.08e-06 | 195 | 164 | 7 | 3c51f005d8546c570752f5f0ce6b8ac242d3c54b | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.53e-06 | 200 | 164 | 7 | 61bae10c8b12196d9cee766897971b81cb897191 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-05 | 139 | 164 | 6 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.70e-05 | 146 | 164 | 6 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 154 | 164 | 6 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 156 | 164 | 6 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-05 | 158 | 164 | 6 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.06e-05 | 162 | 164 | 6 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-05 | 163 | 164 | 6 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | droplet-Liver-Hepatocytes-21m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 164 | 164 | 6 | c9866a289e120be4066e66275c3beb97ba67cca4 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 166 | 164 | 6 | 4b63ecedf21285974f0d188979fcdced27bf9ef9 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 3.51e-05 | 166 | 164 | 6 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 166 | 164 | 6 | d6d29b0dc1ef471b1227495f349963ab37f22ec4 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 168 | 164 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.42e-05 | 173 | 164 | 6 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 174 | 164 | 6 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 176 | 164 | 6 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.02e-05 | 177 | 164 | 6 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 177 | 164 | 6 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 177 | 164 | 6 | 16197068260fc062bf8b730a51a199887ea580b9 | |
| ToppCell | Severe-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.51e-05 | 180 | 164 | 6 | 90b812c5450359b1745b413421b71e291c97086a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.86e-05 | 182 | 164 | 6 | c3eafdc11858566aa7692b2f5dbe72ac01fb769a | |
| ToppCell | HSPCs-Ery/Mk_prog.|HSPCs / Lineage and Cell class | 6.04e-05 | 183 | 164 | 6 | 59cfb02143b6b54dfca7560562e064948f0340ca | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-05 | 183 | 164 | 6 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 6.22e-05 | 184 | 164 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 6.41e-05 | 185 | 164 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.41e-05 | 185 | 164 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 186 | 164 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-05 | 188 | 164 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | HSPCs-Ery/Mk_prog.|World / Lineage and Cell class | 7.01e-05 | 188 | 164 | 6 | 5390089213cd6ee90dcdfd3c3f5b6765376cccf2 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.43e-05 | 190 | 164 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 7.43e-05 | 190 | 164 | 6 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 7.43e-05 | 190 | 164 | 6 | ff083168d609957d00888f31b3488d6d56c902b4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 190 | 164 | 6 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.43e-05 | 190 | 164 | 6 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 190 | 164 | 6 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 191 | 164 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 191 | 164 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.65e-05 | 191 | 164 | 6 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 7.65e-05 | 191 | 164 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.65e-05 | 191 | 164 | 6 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.65e-05 | 191 | 164 | 6 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.87e-05 | 192 | 164 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.10e-05 | 193 | 164 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 193 | 164 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 193 | 164 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | lymphoid-NK_cell-NK_cell|World / Lineage, cell class and subclass | 8.33e-05 | 194 | 164 | 6 | 7f5adc18e632109694446b8eb1543cbae62dccbe | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 8.33e-05 | 194 | 164 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.33e-05 | 194 | 164 | 6 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | lymphoid-NK_cell|World / Lineage, cell class and subclass | 8.33e-05 | 194 | 164 | 6 | 4bf5a140be8691e4ec99d7ee15588fd48acd6fb5 | |
| ToppCell | Mild/Remission-B_memory-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.33e-05 | 194 | 164 | 6 | 4866093b50cdf895f06b60684cc3aaa9769aa4dc | |
| ToppCell | T/NK_cells-CD56bright_NK_cell|T/NK_cells / Lineage and Cell class | 8.57e-05 | 195 | 164 | 6 | d2c8f5c114b1864b509fad449aa4492dfc61113c | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 8.57e-05 | 195 | 164 | 6 | e8ab3122f81cb22920becd6611cbd9f00db19d50 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 8.57e-05 | 195 | 164 | 6 | c3280bb6219e2eff5e24ef45aa2d76479a562122 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.57e-05 | 195 | 164 | 6 | 1e794839a251fbc6e6ce419b4c457ead35a04735 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 8.57e-05 | 195 | 164 | 6 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|COVID-19_Severe / Disease condition and Cell class | 8.57e-05 | 195 | 164 | 6 | 787ea9f38ad8e2a836222ca97f4d927f7e79517d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 196 | 164 | 6 | d323f7dc41380446e5967c69832bea88351a9331 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.82e-05 | 196 | 164 | 6 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue | 8.82e-05 | 196 | 164 | 6 | e6d4853ccefbcd45a019cee595811f0474dcc036 | |
| ToppCell | lymphoid-NK_cell|lymphoid / Lineage, cell class and subclass | 8.82e-05 | 196 | 164 | 6 | 0c7fb03ef782256f61624afc5c1bfaed9f1005fb | |
| ToppCell | lymphoid-NK_cell-NK_cell|lymphoid / Lineage, cell class and subclass | 8.82e-05 | 196 | 164 | 6 | 5e6238fe131e349013c60a73c99f84a6be7955ef | |
| ToppCell | severe-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.82e-05 | 196 | 164 | 6 | 14baf176bce5750ef50d6838b748caf68c151e05 | |
| ToppCell | Control-Myeloid-TRAM3|Control / Disease group,lineage and cell class （2021.01.30） | 9.06e-05 | 197 | 164 | 6 | 733ff40039d67e561c2ded7c9bd0b4353101741e | |
| ToppCell | Control-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.06e-05 | 197 | 164 | 6 | b86385c6c1d52ef4e3d855004d77afab61556978 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.06e-05 | 197 | 164 | 6 | 4416efdbd9c4ac3356a5dff2d535c2d7383376a9 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 9.06e-05 | 197 | 164 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.06e-05 | 197 | 164 | 6 | 0f1c4a328968b32874e6ebb0803e665adcbbc450 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.06e-05 | 197 | 164 | 6 | aafe0cd697b0b7f0756596148e0906443fdf8ef7 | |
| ToppCell | control-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.06e-05 | 197 | 164 | 6 | 8819db1550bf14566c6d33d97f7f83419e867ace | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.06e-05 | 197 | 164 | 6 | e131634bc67e0bd31a938a8e8df8dc752e1d0f47 | |
| ToppCell | Mild/Remission-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.32e-05 | 198 | 164 | 6 | 44906dbf99ddd53335e2d32082ff7e77d91baaeb | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 9.32e-05 | 198 | 164 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.32e-05 | 198 | 164 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | severe-dn_T|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.32e-05 | 198 | 164 | 6 | d4f2213af45ada47e6c62675f468ce05692db507 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass | 9.32e-05 | 198 | 164 | 6 | 75e94298bf03d755fef46df685437d0d29fdbca9 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.32e-05 | 198 | 164 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-05 | 198 | 164 | 6 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | Mild/Remission-B_memory-3|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.58e-05 | 199 | 164 | 6 | 493d043beef70b60338cc199db82592cdc6e635d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-05 | 199 | 164 | 6 | 0902b08e3386e64d7347c186d9ce5b67f2deaabb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.85e-05 | 200 | 164 | 6 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-05 | 200 | 164 | 6 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Sigmoid-T_cell-Tfh|T_cell / Region, Cell class and subclass | 9.85e-05 | 200 | 164 | 6 | dd7dcf25520f065bf0d33d589f3c176f63875dc9 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Bdnf_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 69 | 164 | 4 | 24a480394630385ee51b1dfe1123480107a11403 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Bdnf_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 69 | 164 | 4 | 1ab1d92e03a31bb1fe87f055d407a81c4d1d81b8 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 142 | 164 | 5 | 58bfff3284ae21150e4619511bd58622c16c5dde | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 142 | 164 | 5 | 5fd737c1fee9d97aee8955f1bf378ead3fce138d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 142 | 164 | 5 | 16f9945e835c3506b12d904778560d065a50f059 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 142 | 164 | 5 | ae495c8dd733f0fde66bddc281606543f21c0d4b | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; HL60; HT_HG-U133A | 1.71e-06 | 198 | 163 | 10 | 2164_DN | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.79e-06 | 199 | 163 | 10 | 5697_UP | |
| Drug | cadmium selenide | 4.16e-06 | 34 | 163 | 5 | ctd:C058667 | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; PC3; HT_HG-U133A | 1.19e-05 | 195 | 163 | 9 | 4647_UP | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.19e-05 | 195 | 163 | 9 | 4399_DN | |
| Drug | Fullerenes | 1.21e-05 | 42 | 163 | 5 | ctd:D037741 | |
| Drug | zinc sulfide | 3.18e-05 | 51 | 163 | 5 | ctd:C031238 | |
| Drug | Tosyllysine Chloromethyl Ketone | 3.91e-05 | 27 | 163 | 4 | ctd:D014107 | |
| Drug | 2-stearoylglycerol | 5.09e-05 | 2 | 163 | 2 | CID000079075 | |
| Drug | AC1Q4UMG | 6.00e-05 | 30 | 163 | 4 | CID000093587 | |
| Drug | camalexin | 6.85e-05 | 31 | 163 | 4 | CID000636970 | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 7.81e-05 | 193 | 163 | 8 | 4460_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.81e-05 | 193 | 163 | 8 | 4380_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 7.81e-05 | 193 | 163 | 8 | 3811_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; PC3; HT_HG-U133A | 8.10e-05 | 194 | 163 | 8 | 4506_UP | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 8.10e-05 | 194 | 163 | 8 | 3938_UP | |
| Drug | poly I | 8.28e-05 | 250 | 163 | 9 | CID000000797 | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 3163_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 4686_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 6770_DN | |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 5350_UP | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 3716_DN | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 4623_UP | |
| Drug | daunorubicin HCl; Up 200; 1uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 7511_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 2301_UP | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 3183_DN | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 4490_UP | |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 2817_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 2191_UP | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 4555_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 3256_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 5249_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; HL60; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 1272_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; HL60; HG-U133A | 9.34e-05 | 198 | 163 | 8 | 1438_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 5102_UP | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 6622_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; HL60; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 6155_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 1648_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.00e-04 | 200 | 163 | 8 | 4646_UP | |
| Drug | Poly I-C | 1.10e-04 | 105 | 163 | 6 | ctd:D011070 | |
| Disease | ALZHEIMER DISEASE 4 | 2.78e-05 | 2 | 156 | 2 | 606889 | |
| Disease | ALZHEIMER DISEASE 4 | 2.78e-05 | 2 | 156 | 2 | C1847200 | |
| Disease | Alzheimer disease 4 | 2.78e-05 | 2 | 156 | 2 | cv:C1847200 | |
| Disease | Schizophrenia | A1BG PSEN2 ANK3 DDO APOE LILRB1 CHRNB2 ADAMTS12 MLC1 TLR3 ERVK-8 KIF2A CTNND2 ZKSCAN4 CADPS2 | 7.37e-05 | 883 | 156 | 15 | C0036341 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.63e-04 | 152 | 156 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Primary microcephaly | 2.07e-04 | 22 | 156 | 3 | C0431350 | |
| Disease | Herpetic Acute Necrotizing Encephalitis | 2.75e-04 | 5 | 156 | 2 | C0001338 | |
| Disease | Herpetic meningoencephalitis | 4.11e-04 | 6 | 156 | 2 | C0019385 | |
| Disease | entorhinal cortical volume | 4.11e-04 | 6 | 156 | 2 | EFO_0005092 | |
| Disease | asthma, cardiovascular disease | 5.30e-04 | 30 | 156 | 3 | EFO_0000319, MONDO_0004979 | |
| Disease | Primary familial dilated cardiomyopathy | 5.30e-04 | 30 | 156 | 3 | cv:C0340427 | |
| Disease | Early-onset autosomal dominant Alzheimer disease | 5.73e-04 | 7 | 156 | 2 | cv:CN043596 | |
| Disease | Herpes encephalitis | 5.73e-04 | 7 | 156 | 2 | C0276226 | |
| Disease | Severe Congenital Microcephaly | 5.84e-04 | 31 | 156 | 3 | C3853041 | |
| Disease | Malignant neoplasm of breast | MAGEA4 TICAM1 PPP1R12B DEPP1 ARFGEF2 DDO DYSF TMEM25 OTOGL NISCH NFKBIA UQCC1 USP54 ZNHIT2 NLRP8 | 5.98e-04 | 1074 | 156 | 15 | C0006142 |
| Disease | Microlissencephaly | 7.04e-04 | 33 | 156 | 3 | C1956147 | |
| Disease | Alzheimer disease | 7.62e-04 | 8 | 156 | 2 | cv:C0002395 | |
| Disease | Embryonal Rhabdomyosarcoma | 7.62e-04 | 8 | 156 | 2 | C0206656 | |
| Disease | Primary dilated cardiomyopathy | 7.69e-04 | 34 | 156 | 3 | cv:C0007193 | |
| Disease | Coronavirus infectious disease (implicated_via_orthology) | 9.76e-04 | 9 | 156 | 2 | DOID:0080599 (implicated_via_orthology) | |
| Disease | Thrombophilia | 9.76e-04 | 9 | 156 | 2 | C0398623 | |
| Disease | chronic fatigue syndrome (is_marker_for) | 1.22e-03 | 10 | 156 | 2 | DOID:8544 (is_marker_for) | |
| Disease | colitis (biomarker_via_orthology) | 1.43e-03 | 42 | 156 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 1.43e-03 | 42 | 156 | 3 | DOID:612 (is_implicated_in) | |
| Disease | GM3 ganglioside measurement | 1.48e-03 | 11 | 156 | 2 | EFO_0021451 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 1.48e-03 | 11 | 156 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | platelet measurement | 1.49e-03 | 315 | 156 | 7 | EFO_0005036 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.53e-03 | 43 | 156 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | Familial dilated cardiomyopathy | 1.64e-03 | 44 | 156 | 3 | C0340427 | |
| Disease | Cardiomyopathy | 1.98e-03 | 47 | 156 | 3 | cv:C0878544 | |
| Disease | plasma beta-amyloid 1-42 measurement | 2.08e-03 | 13 | 156 | 2 | EFO_0005660 | |
| Disease | rostral anterior cingulate cortex volume measurement | 2.08e-03 | 13 | 156 | 2 | EFO_0010327 | |
| Disease | Malformations of Cortical Development | 2.42e-03 | 14 | 156 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.42e-03 | 14 | 156 | 2 | C0431380 | |
| Disease | immature platelet count | 2.46e-03 | 106 | 156 | 4 | EFO_0803544 | |
| Disease | Germ Cell Cancer | 2.79e-03 | 15 | 156 | 2 | C0740345 | |
| Disease | Embryonal Neoplasm | 2.79e-03 | 15 | 156 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 2.79e-03 | 15 | 156 | 2 | C0027658 | |
| Disease | Germ cell tumor | 2.79e-03 | 15 | 156 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 2.79e-03 | 15 | 156 | 2 | C0205852 | |
| Disease | Cancer, Embryonal | 2.79e-03 | 15 | 156 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 2.79e-03 | 15 | 156 | 2 | C0751365 | |
| Disease | Multiple congenital anomalies | 3.59e-03 | 17 | 156 | 2 | C0000772 | |
| Disease | caudal anterior cingulate cortex volume measurement | 3.59e-03 | 17 | 156 | 2 | EFO_0010289 | |
| Disease | keratinocyte carcinoma | 3.62e-03 | 118 | 156 | 4 | EFO_0010176 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.87e-03 | 195 | 156 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | nephrotic syndrome (is_marker_for) | 4.02e-03 | 18 | 156 | 2 | DOID:1184 (is_marker_for) | |
| Disease | triacylglycerol 56:3 measurement | 4.02e-03 | 18 | 156 | 2 | EFO_0010430 | |
| Disease | acne | 4.44e-03 | 125 | 156 | 4 | EFO_0003894 | |
| Disease | neuroimaging measurement | ANK3 TNRC6B APOE DYSF MAPK8IP3 TAOK2 CYRIA PROSER3 TNRC6A NINL UQCC1 TLN2 EPHA4 | 4.56e-03 | 1069 | 156 | 13 | EFO_0004346 |
| Disease | docosahexaenoic acid measurement | 4.70e-03 | 127 | 156 | 4 | EFO_0007761 | |
| Disease | late-onset Alzheimers disease | 4.71e-03 | 292 | 156 | 6 | EFO_1001870 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQSNEEGPGEWLTLD | 86 | Q9UPW8 | |
| GAQRDSGLVSQQLPW | 826 | Q14146 | |
| NELQAGPWNTGRSLE | 306 | O60566 | |
| QAAPGVRGEEEQWAR | 121 | Q9BXH1 | |
| LQSWTDNERSIPNDG | 316 | Q9H6S1 | |
| GALEPAQQLSSLEGW | 16 | Q96M42 | |
| LQWNAGSGGLPENET | 116 | P51689 | |
| IIQWNGPESNSGERL | 171 | O75366 | |
| NNEFGTIIDWAPRGQ | 256 | O71037 | |
| NNEFGTIIDWAPRGQ | 256 | Q902F8 | |
| QVLQWLSGPGEEQLA | 791 | Q8TER5 | |
| LAGQPLQERAQAWGE | 216 | P02649 | |
| DSDSRPGQELLVAWN | 11 | Q9UJX6 | |
| QGELVPEAWGLRQEG | 631 | A6NC98 | |
| GPGVGWENSAETLQE | 1436 | A6NC98 | |
| ENIQWSIDPGADLSQ | 651 | Q99708 | |
| QGSSEGLRQNVDVWL | 216 | P46952 | |
| VNGAKWNPRTGTIND | 846 | Q8IUX7 | |
| DWLFGESQEKQPSQR | 106 | Q9NTK1 | |
| VRNPDQRNTDEDKWG | 331 | P49747 | |
| ERGQSQLSNPTDDSW | 1521 | Q9Y6D5 | |
| GNTIEIQGDDAPSLW | 161 | P53674 | |
| AQPGGTGEEQWERSR | 21 | Q17RM4 | |
| PWERGDGQDVSARQA | 291 | P16066 | |
| QGTQLGDILPNANWT | 246 | P29016 | |
| ERWEQQVSAADGKPG | 1216 | Q6W2J9 | |
| SESDNWRDRNGIGPG | 811 | Q9H694 | |
| SGWENSPLQDDRKIQ | 691 | Q9UQB3 | |
| EGSQLDASDWLNPAQ | 431 | O14525 | |
| DLGGKQWQDSSTQPE | 1061 | P58397 | |
| NRLEWRGEGEAPQSL | 586 | P25098 | |
| QLGTGQDEDAWSPVE | 376 | P18754 | |
| QTPGLWESENQNKGV | 171 | Q9NP72 | |
| SEVGPLLQGTNSQWE | 306 | Q5T481 | |
| LEQSEWQPTNVDGKG | 241 | P10914 | |
| KAGDRVANPEQGLWN | 71 | Q4KMZ1 | |
| GGETAQSADPQWEQL | 31 | P05546 | |
| LSHDTQQWGDVLPDG | 246 | Q29983 | |
| NQNGWSGDSAPVELI | 286 | P04217 | |
| EGQAAEAQSRIPWDS | 361 | Q9NZ53 | |
| NRTEGLLGVWNNNPE | 4831 | Q99102 | |
| QPTEGEREIWNQISA | 26 | Q9H0Q0 | |
| SGLVNGRKNESEPWQ | 96 | Q5HY92 | |
| NLWISRTQESGDQDP | 476 | O00515 | |
| WRQPNEGSSSQEEEG | 81 | P43358 | |
| AGVNLSGWRPNEDDA | 711 | Q9UPT6 | |
| TPRIWTDLGNNLQGN | 801 | Q86W28 | |
| NERDLLGTVWGGPAN | 281 | Q9NTX5 | |
| ESTNGAGPWQDELAA | 761 | Q76N89 | |
| NWDPQQRGGPVDLTL | 281 | O15111 | |
| SFGNWGQDNELLEPL | 571 | Q8NBH2 | |
| IAGAQRRENGPLEWS | 246 | Q14164 | |
| QPSDENWDLTGTRQI | 1251 | O15054 | |
| LEWSSPQNTGGRQDI | 346 | P54764 | |
| EPVLSAEAWLQGANG | 836 | P57737 | |
| EQQGWNDSRGPEGML | 126 | Q5JVS0 | |
| VEGEGPQNGERKVNW | 76 | O43593 | |
| ARVWAPGDAGQQKES | 696 | O43593 | |
| LQEGQEDGPAGWRAN | 576 | Q8IY33 | |
| ANQPGWRGELQEEGA | 551 | Q9H6A9 | |
| TPEIQRGDWGQQELL | 4036 | Q9NYQ8 | |
| EWTLAGTGQEAQAAP | 196 | Q96B70 | |
| QWRQPSLDVEVGDPN | 461 | Q01064 | |
| GPLRLQVWDQDSGRD | 476 | P14222 | |
| LEGSGQWPQDAEAVQ | 741 | Q9H6R4 | |
| WGQGPEKQVAERQQS | 861 | Q5T7B8 | |
| TQADPTGRLLDAWQG | 66 | Q99836 | |
| LPQTLQDVGGWENET | 1496 | P09848 | |
| WLNGREEDVGQPRLQ | 66 | P53602 | |
| RGSEPWKQQLTEDGD | 61 | P25963 | |
| PQEDALTGSRVWNNS | 531 | Q96EN8 | |
| QGTEGAIKWNEANRP | 1546 | P00451 | |
| ENSGDPWLKGRNSQN | 246 | A8MYU2 | |
| GDPKGWRQLAQEAEA | 311 | P00973 | |
| SGLDPNGEQVVWQAS | 191 | Q9HBH1 | |
| DLDRIQASQWPGVNG | 551 | O95402 | |
| NNEFGTIIDWAPRGQ | 1016 | P63135 | |
| TRQKGDWNLSPDAEN | 236 | Q99489 | |
| PNQIDDLETQWGVGS | 571 | O00139 | |
| DLETQWGVGSSPQRD | 576 | O00139 | |
| SWNGDQDAGPLLVEN | 686 | Q9NZ94 | |
| NQQDGQLEDSPGLWP | 201 | Q96IJ6 | |
| GNDAGWTQISREQVP | 546 | A1L0T0 | |
| RTSGPSEWQLQQEAA | 281 | Q8IXT2 | |
| NNEFGTIIDWAPRGQ | 256 | P61570 | |
| NNEFGTIIDWAPRGQ | 256 | Q69384 | |
| WELAQDQLIRNSGSG | 581 | Q8NCL4 | |
| GPSQAGAEENDWVRL | 31 | Q9BT09 | |
| KDSQSWIGGNNEPLT | 121 | Q8NHH9 | |
| PGTEGRLAGQWVEQE | 86 | Q9NWK9 | |
| PVDGWQNETSSGNLE | 4196 | Q12955 | |
| QAEASRPQWGTQGDF | 401 | Q86UW7 | |
| SQWEGRANGISNPEK | 26 | Q68D51 | |
| DGSPNWDGNSEEILG | 1036 | Q6UXX5 | |
| GEQEPITVDQTWRGD | 151 | Q9H9L4 | |
| TQPQGVLSRNDWRAG | 76 | C9JBD0 | |
| NNEFGTLIDWAPRGQ | 256 | Q902F9 | |
| VSWEASRTPQGQLQG | 1971 | Q9BYK8 | |
| EKGATWNVLDDQPRG | 121 | Q9UPN4 | |
| EEVFENQTRLPGGQW | 951 | O75923 | |
| GPEAARLEWRAQGQA | 31 | Q3KP66 | |
| GWTGPLDSQELLQQE | 126 | Q5FWE3 | |
| EQGGEASPQRTWEQQ | 226 | Q9UJU6 | |
| WDPSENARIGNQDTK | 141 | Q6W0C5 | |
| DQPRTAGEIWNGGID | 1871 | Q3ZCN5 | |
| GDRPWLRGEDQSEQE | 156 | Q96C34 | |
| QRPRGDGQDWDAASS | 321 | Q86VV8 | |
| SPIQIDGAGRTWQDS | 326 | Q8NFQ8 | |
| RNDLDPRVLSNTGWG | 436 | Q9HCJ0 | |
| GPSQRDWQNESKEGL | 336 | Q6ZUK4 | |
| GLPDKDRSGVNSWQV | 376 | Q17RD7 | |
| QPGRENFQNWLKDGT | 46 | P37802 | |
| GLQWRSSPAADAQEE | 516 | Q8NHL6 | |
| GDTFGEDWQQTPLRQ | 386 | Q92529 | |
| EDWQQTPLRQGSSDI | 391 | Q92529 | |
| SQGNLTESWADDNPR | 406 | Q9Y286 | |
| PQERSIVGQEEAGTW | 856 | Q9UL54 | |
| LEQAQGSKGDRAWVP | 296 | Q2NL68 | |
| ERGTLGQPLNWEAAT | 241 | Q9NRC8 | |
| SPTDEDTQGPNRLWN | 3346 | Q9P2P6 | |
| GREPSQWQSRTENGG | 4046 | Q9P2P6 | |
| WGLQEQLQDTARGPE | 691 | Q9Y2I6 | |
| NEWLSPRAGEGLNSQ | 86 | O15130 | |
| RNLIDEDGTNHWPEG | 126 | O60518 | |
| ESPEQQGRSTAWGLQ | 1741 | Q7RTU9 | |
| PGSEQLRAQWGIGDS | 291 | Q86VW0 | |
| GEWDIVALPGRRNEN | 201 | P17787 | |
| SPIDERNNGTITWEN | 396 | P21589 | |
| QVPGGSQELVQLWND | 86 | E9PGG2 | |
| NQGEPNDAWGRENCV | 251 | Q6UXB4 | |
| PGQTRDWNEELQTTR | 351 | O75153 | |
| NRQELGRWLQEEPGA | 106 | P11086 | |
| WENSTEVPREAGDGQ | 41 | Q6ZNH5 | |
| NEIGQELTGQEWRGL | 441 | O15455 | |
| TTWNTNVGIINEDPG | 751 | Q8NER1 | |
| VGAIPANALDDGQWS | 2376 | Q9Y490 | |
| WNQRGSQAPEDKTQE | 696 | Q8IUC6 | |
| NISVWDDVGNLIQPG | 51 | Q9BQ15 | |
| PDGALGQRDQSSWQN | 1036 | Q9C0C2 | |
| GGPARASQGREVQWQ | 1456 | Q9Y2I1 | |
| QRWIDNPTVDDRGVG | 501 | P18206 | |
| QGPEDGENTAQWRSQ | 36 | P49810 | |
| EVWTRDPANQSTQGA | 716 | Q2M1Z3 | |
| DNGTTPGAEGWRQLL | 261 | Q5SNT2 | |
| QGQGDRALSRTSQWP | 31 | Q9NVA1 | |
| EWKNPESQRGLSGTQ | 81 | O15213 | |
| NWPRELKDGNGQESL | 361 | P36402 | |
| GGQSRDSDQAPEDRW | 496 | Q8IUG5 | |
| REDETWGRSQQNSGP | 301 | Q53FD0 | |
| LDSEGQEPALRSWGN | 1271 | O43379 | |
| DQEKQQQASEGRPWS | 126 | P52736 | |
| QQASEGRPWSDQAEG | 131 | P52736 | |
| QGRTESQWENTEAPV | 471 | Q969J2 | |
| WNRGAGPQLLEELDN | 131 | Q9UHR6 | |
| PANAADDGQWSQGLI | 2381 | Q9Y4G6 | |
| PGDWSQQDIGTNLVE | 1406 | Q13395 | |
| TTQWEDPRTQGLQNE | 481 | Q9H0M0 | |
| GFPTEAERQQWKQEG | 11 | Q6P3X3 | |
| LGWLDEQQQPLGGSS | 446 | P0DP72 | |
| AQWSQAQLSDGELGR | 481 | Q5TAA0 | |
| QGDSSGRLNIWNISD | 346 | Q9Y4E6 | |
| ELQSWVRGQRPESGE | 101 | O95125 | |
| PGLDSQWRQIENGES | 76 | P51784 | |
| GWQVLDATPQEESEG | 351 | O95932 | |
| TDLDPRVLSNSGWGQ | 711 | Q8NDV7 | |
| GTRANLTGWDPQKDL | 376 | Q06418 | |
| LSSGWGELEPQIDGQ | 21 | Q86YD3 | |
| GELEPQIDGQTWAER | 26 | Q86YD3 | |
| ALLQAWGGQPEALSE | 321 | C9JLR9 | |
| TDLDPRVLSNTGWGQ | 611 | Q9UPQ9 | |
| WQSLETGQNQSDPVG | 1746 | Q9UPQ9 | |
| PEENAPSEGQRVWGQ | 236 | P78423 | |
| QQSSLEGGDRPLSWE | 1186 | Q70EL1 | |
| NNDGTLVLGATNIPW | 261 | Q9UN37 | |
| QGASWDTQNGPQERL | 336 | Q15049 | |
| GLLASENWTLGQNDR | 1536 | Q6PIF6 | |
| AGEGQQPWGRSLDEE | 701 | O60237 | |
| RLDGQWPDGLLASDN | 306 | Q9NQS3 |